Author

Amy Diallo

University of California, San FranciscoORCID 0000-0001-9843-2255Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Molecular Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

Mélanie OttiD· 3 shared Nevan J. KroganiD· 3 shared Rahul K. SuryawanshiiD· 3 shared Taha Y. TahaiD· 3 shared Danielle L. SwaneyiD· 2 shared Irene P. CheniD· 2 shared Kliment A. VerbaiD· 2 shared Adam R. RensloiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersSystems Biology

Mélanie OttORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Systems BiologyCell Host & MicrobePeer-reviewedMay 14, 2026

Coronavirus protein interaction mapping in bat and human cells identifies molecular and genetic switches for immune evasion and replication

Jyoti Batra, Magdalena Rutkowska, Yuan Zhou…·Nevan J. Krogan

4 citationstop 1%

𝕏 PostBluesky

BiochemistryScience AdvancesPeer-reviewedApr 23, 2025

Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus-MPro inhibitors with potent in vivo efficacy

Tyler C. Detomasi, Gilles Degotte, Sijie Huang…·Charles S. Craik

This paper describes the discovery of new coronavirus MPro inhibitors with improved pharmacokinetics, broad-spectrum antiviral activity, and superior in vivo efficacy compared to existing drugs.

16 citationstop 1%

humanproteomics

𝕏 PostBluesky

Molecular BiologyCell ReportsPeer-reviewedJun 27, 2022

Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2

Irene P. Chen, James E. Longbotham, Sarah McMahon…·Mélanie Ott

The paper shows that BET proteins are antiviral factors against SARS-CoV-2, and the viral E protein neutralizes BET-mediated post-entry antiviral effects.

28 citations

humanstatistical model

𝕏 PostBluesky